Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kämpe O (enero de 2000). «Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I». Biochem. Biophys. Res. Commun.267 (1): 456-61. PMID10623641. doi:10.1006/bbrc.1999.1945.
Ono M, Okamoto M, Kawabe N, Umezawa H, Takeuchi T (marzo de 1971). «Oudenone, a novel tyrosine hydroxylase inhibitor from microbial origin». J. Am. Chem. Soc.93 (5): 1285-6. PMID5545929. doi:10.1021/ja00734a054.
nih.gov
ncbi.nlm.nih.gov
Nagatsu T (1995). «Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology». Essays Biochem.30: 15-35. PMID8822146.
Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kämpe O (enero de 2000). «Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I». Biochem. Biophys. Res. Commun.267 (1): 456-61. PMID10623641. doi:10.1006/bbrc.1999.1945.
Ono M, Okamoto M, Kawabe N, Umezawa H, Takeuchi T (marzo de 1971). «Oudenone, a novel tyrosine hydroxylase inhibitor from microbial origin». J. Am. Chem. Soc.93 (5): 1285-6. PMID5545929. doi:10.1021/ja00734a054.
Ayukawa S, Takeuchi T, Sezaki M, Hara T, Umezawa H (mayo de 1968). «Inhibition of tyrosine hydroxylase by aquayamycin». J. Antibiot.21 (5): 350-3. PMID5726288.